A B DeLeo - JoVE Visualize

Showing results (31-40 of 53) with videos related to

Pageof 6

Sort By:

Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1986

Molecular basis of a unique tumor antigen of radiation leukemia virus-induced leukemia B6RV2: its relation to MuLV gp70 of xenotropic classE Nakayama, A Uenaka, A B DeLeo, et al.

The Journal of Experimental Medicine|September 1, 1981

A cell surface antigen of the mouse related to xenotropic MuLv defined by naturally occurring antibody and monoclonal antibody. Relation to Gix G(rada1), G(aksl2) systems of MuLV-related antigensY Obata, E Stockert, A B DeLeo, et al.

Proceedings of the National Academy of Sciences of the United States of America|May 1, 1979

Detection of a transformation-related antigen in chemically induced sarcomas and other transformed cells of the mouseA B DeLeo, G Jay, E Appella, et al.

International Journal of Cancer|June 15, 1982

possible role of a retrovirus in the expression of tumor-specific antigens of the Meth A sarcomaA B DeLeo, K S Chang, N A Wivel, et al.

Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1994

Role of CD44 in the development of natural killer cells from precursors in long-term cultures of mouse bone marrowD V Delfino, K D Patrene, A B DeLeo, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 2, 1999

Generation of anti-p53 cytotoxic T lymphocytes from human peripheral blood using autologous dendritic cellsK Chikamatsu, K Nakano, W J Storkus, et al.

Cancer Research|January 1, 1995

Identification of Meth A sarcoma-derived class I major histocompatibility complex-associated peptides recognized by a specific CD8+ cytotoxic T lymphocyteM A Frassanito, J I Mayordomo, R M DeLeo, et al.

Proceedings of the National Academy of Sciences of the United States of America|October 1, 1983

Protein p53 and inducer-mediated erythroleukemia cell commitment to terminal cell divisionD W Shen, F X Real, A B DeLeo, et al.

Gene Therapy|February 15, 2001

Immunogenicity of enhanced green fluorescent protein (EGFP) in BALB/c mice: identification of an H2-Kd-restricted CTL epitopeA Gambotto, G Dworacki, V Cicinnati, et al.

The Journal of Experimental Medicine|April 1, 1989

Monoclonal antibody to a triggering structure expressed on rat natural killer cells and adherent lymphokine-activated killer cellsW H Chambers, N L Vujanovic, A B DeLeo, et al.

Pageof 6

Showing results (31-40 of 53) with videos related to

Sort By:

Pageof 6

Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1986

Molecular basis of a unique tumor antigen of radiation leukemia virus-induced leukemia B6RV2: its relation to MuLV gp70 of xenotropic classE Nakayama, A Uenaka, A B DeLeo, et al.

The Journal of Experimental Medicine|September 1, 1981

A cell surface antigen of the mouse related to xenotropic MuLv defined by naturally occurring antibody and monoclonal antibody. Relation to Gix G(rada1), G(aksl2) systems of MuLV-related antigensY Obata, E Stockert, A B DeLeo, et al.

Proceedings of the National Academy of Sciences of the United States of America|May 1, 1979

Detection of a transformation-related antigen in chemically induced sarcomas and other transformed cells of the mouseA B DeLeo, G Jay, E Appella, et al.

International Journal of Cancer|June 15, 1982

possible role of a retrovirus in the expression of tumor-specific antigens of the Meth A sarcomaA B DeLeo, K S Chang, N A Wivel, et al.

Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1994

Role of CD44 in the development of natural killer cells from precursors in long-term cultures of mouse bone marrowD V Delfino, K D Patrene, A B DeLeo, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 2, 1999

Generation of anti-p53 cytotoxic T lymphocytes from human peripheral blood using autologous dendritic cellsK Chikamatsu, K Nakano, W J Storkus, et al.

Cancer Research|January 1, 1995

Identification of Meth A sarcoma-derived class I major histocompatibility complex-associated peptides recognized by a specific CD8+ cytotoxic T lymphocyteM A Frassanito, J I Mayordomo, R M DeLeo, et al.

Proceedings of the National Academy of Sciences of the United States of America|October 1, 1983

Protein p53 and inducer-mediated erythroleukemia cell commitment to terminal cell divisionD W Shen, F X Real, A B DeLeo, et al.

Gene Therapy|February 15, 2001

Immunogenicity of enhanced green fluorescent protein (EGFP) in BALB/c mice: identification of an H2-Kd-restricted CTL epitopeA Gambotto, G Dworacki, V Cicinnati, et al.

The Journal of Experimental Medicine|April 1, 1989

Monoclonal antibody to a triggering structure expressed on rat natural killer cells and adherent lymphokine-activated killer cellsW H Chambers, N L Vujanovic, A B DeLeo, et al.

Pageof 6